SPERIAN PROTECTION INVESTMENT, INC. – Trademark Portfolio
Entity Type: 03
SPERIAN PROTECTION INVESTMENT, INC. holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 25 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include PROLOK, V-MAXX, FOG-BAN, FREEDOM, and POLYSAFE. The owner is based in SMITHFIELD, RI.
900 DOUGLAS PIKE
SMITHFIELD, RI 02917
Showing of trademarks Trademarks
Trademark Classifications
SPERIAN PROTECTION INVESTMENT, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does SPERIAN PROTECTION INVESTMENT, INC. have?
SPERIAN PROTECTION INVESTMENT, INC. has 27 U.S. trademarks filed with the USPTO. Of these, 6 registered, 21 cancelled.
What trademark classes does SPERIAN PROTECTION INVESTMENT, INC. file in?
SPERIAN PROTECTION INVESTMENT, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are SPERIAN PROTECTION INVESTMENT, INC.'s most well-known trademarks?
SPERIAN PROTECTION INVESTMENT, INC.'s registered trademark portfolio includes well-known marks such as PROLOK, V-MAXX, FOG-BAN, FREEDOM, and POLYSAFE. These are among 6 currently registered trademarks in the portfolio.
What is SPERIAN PROTECTION INVESTMENT, INC.'s trademark registration success rate?
SPERIAN PROTECTION INVESTMENT, INC. has a 22% trademark registration rate, with 6 out of 27 resolved applications resulting in successful registration. Currently, 0 applications are pending review.